Block Listing Six Monthly Return

Induction Healthcare Group PLC

(“Induction”, the “Company”, or the “Group”)

Block Listing Six Monthly Return

Induction Healthcare (AIM: INHC), a leading digital health platform driving transformation of healthcare systems worldwide, makes the following six monthly update on its block listing pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for Companies:Name of applicant:Induction Healthcare Group PLCLEI: 213800RY96GCZQW5TP19Name of scheme:The Induction Healthcare NTA Share Option PlanPeriod of return: From:26/01/2022To:26/07/2022Number and class of securities originally admitted and the date of admission3,500,000 ordinary shares on 26 July 2021Balance of unallotted securities under scheme(s) from initial application:3,500,000Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):nilLess: Number of securities issued/allotted under scheme(s) during the period:396,567Equals: Balance under scheme(s) not yet issued/allotted at end of period:3,103,433Contact:Alison Talbot, Company Secretary+44 (0) 3339 398 091ENQUIRIES InductionJames Balmain, Chief Executive OfficerGuy Mitchell, Chief Financial OfficerVia Walbrook PR Ltd: induction@walbrookpr.com Singer Capital Markets (Nominated Adviser and Broker)+44 (0) 20 7496 3000Philip Davies / Kailey Aliyar Walbrook PR Ltd induction@walbrookpr.comPaul McManus / Alice WoodingsMob: +44(0)7980 541 893 / +44 (0)7407 804 654 About Induction - www.inductionhealthcare.comInduction (AIM: INHC) Induction delivers a suite of software solutions through a single integrated platform that transforms care delivery. Our system-wide applications help healthcare providers and administrators to deliver care at any stage remotely as well as face-to-face – giving the communities they serve greater flexibility, control and ease of access. Purpose-built for integration with leading Electronic Medical Record (EMR) platforms, our products offer immediate stand-alone value that becomes even greater when integrated with pre-existing systems.Used at scale by national and regional healthcare systems, as well non-health government services, our applications are relied upon by hundreds of thousands of clinicians and millions of patients across almost every hospital in the British Isles.